Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 03 - 30 sector : Professional, scientific, and technical services save search
CLINUVEL Communiqué II
Published: 2022-03-30 (Crawled : 01:00) - clinuvel.com
CLVLY | $9.75 31.84% 1.6K
|
Professional, Scientific, and T...
|
| O: -2.49%
H: 0.0%
C: -0.92%
Miromatrix Reports Fourth Quarter and Full Year 2021 Results and Provides Corporate Update
Published: 2022-03-30 (Crawled : 22:00) - biospace.com/
MIRO | $3.39 3.25% 630K
|
Professional, Scientific, and T...
|
| O: -0.27%
H: 6.98%
C: 1.89%
results
LianBio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Published: 2022-03-30 (Crawled : 21:00) - globenewswire.com
LIAN | $4.92 0.41% 0.41% 410K
|
Professional, Scientific, and T...
|
| O: 1.96%
H: 16.21%
C: 1.92%
results
Aerovate Therapeutics Announces Full-Year 2021 Financial Results
Published: 2022-03-30 (Crawled : 21:00) - globenewswire.com
AVTE M | $21.6 -4.0% -4.17% 220K
|
Professional, Scientific, and T...
|
| O: 0.33%
H: 4.69%
C: 1.83%
therapeutics results
Prometheus Biosciences Initiates Third Phase 2 Study of PRA023 for Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)
Published: 2022-03-30 (Crawled : 13:20) - biospace.com/
RXDX | $199.92 0.02% 1.9M
|
Professional, Scientific, and T...
|
| O: 0.34%
H: 1.67%
C: -3.47%
pra023 disease phase 2
Compass Therapeutics Announces Presentation on CTX-8371, A Bispecific Antibody Targeting PD-1 and PD-L1, at the 2022 AACR Annual Meeting in New Orleans
Published: 2022-03-30 (Crawled : 13:20) - biospace.com/
CMPX | $1.5 -1.96% -2.0% 240K
|
Professional, Scientific, and T...
|
| O: 0.79%
H: 10.24%
C: 4.72%
ctx-8371 antibody therapeutics presentation
Benzinga Listmakers - Top 24 EV & Allied Companies
Published: 2022-03-30 (Crawled : 13:20) - prnewswire.com
EMBK | $2.88 0.35% 0.17% 0
|
Professional, Scientific, and T...
|
| O: -0.65%
H: 3.42%
C: -2.44%
MULN | News | $2.9 0.69% 0.69% 680K
|
Information
|
| O: -3.4%
H: 38.77%
C: 33.48%
WEJO | $0.045 11.11% 23M
|
n/a
|
| O: 0.24%
H: 1.2%
C: -2.65%
WKSP | $0.389 3.65% 3.52% 140K
|
Manufacturing
|
| O: 0.0%
H: 0.0%
C: -0.84%
LCID | $2.445 1.03% 1.02% 21M
|
|
| O: -0.66%
H: 3.51%
C: -2.5%
FREY | $1.65 -2.37% 0.61% 990K
|
|
| O: 2.33%
H: 4.2%
C: 0.79%
KULR | $0.408 -15.02% -0.12% 7.2M
|
Manufacturing
|
| O: -0.83%
H: 2.52%
C: -2.94%
F | $12.06 0.17% 0.08% 40M
|
Consumer Durables
|
| O: -1.3%
H: 0.8%
C: -1.43%
companies
Panamera Holdings Corporation Acquires Arsham Aluminum Alloys, LLC
Published: 2022-03-30 (Crawled : 12:20) - prnewswire.com
PHCI 4 | $0.9575 0% 200
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
corporation
Eco Innovation's Next-Gen Cannabis Extraction Technology on Track for Full Commercial Launch as U.S. House Considers Federal Cannabis Legalization
Published: 2022-03-30 (Crawled : 12:20) - prnewswire.com
ECOX | $0.0001 0.0% 72M
|
Professional, Scientific, and T...
|
| O: 18.52%
H: 100.0%
C: 12.5%
cannabis technology commercialization
VectivBio Announces Japan License Deal and Loan Facility Agreement, Providing up to $117 Million to Fuel the Company Through Key Catalysts
Published: 2022-03-30 (Crawled : 12:20) - globenewswire.com
VECT | $16.85 0.12% 130K
|
Professional, Scientific, and T...
|
| O: -0.99%
H: 1.0%
C: 1.0%
deal license
UpHealth Announces Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-03-30 (Crawled : 12:00) - prnewswire.com
UPH | $0.3 9.13% 0.0% 350K
|
Professional, Scientific, and T...
|
| O: -12.12%
H: 0.0%
C: -22.41%
results
Design Therapeutics Completes Dosing in First Patient Cohort of Phase 1 Trial of DT-216 GeneTAC™ Molecule for the Treatment of Friedreich Ataxia
Published: 2022-03-30 (Crawled : 11:00) - globenewswire.com
DSGN | $3.75 -4.82% -5.07% 280K
|
Professional, Scientific, and T...
|
| O: -0.06%
H: 2.91%
C: -2.79%
dt-216 treatment trial therapeutics designation phase 1 friedreich’s ataxia
Liver Cancer Drugs Market - 42% of Growth to Originate from North America | Evolving Opportunities with AstraZeneca Plc & Bayer AG| 17000+ Technavio Reports
Published: 2022-03-30 (Crawled : 03:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: -5.22%
H: 6.2%
C: 1.91%
QBIO | $0.0001 100.0% 500
|
Professional, Scientific, and T...
|
| O: 0.0%
H: 0.0%
C: -15.0%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.58%
H: 0.56%
C: -0.07%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: 0.42%
H: 1.49%
C: 1.34%
america liver cancer growth market
Construction Management Software Size to Grow by USD 1.13 Bn| Increasing Requirements for Large-Scale Project Management to boost market growth| Technavio
Published: 2022-03-30 (Crawled : 02:00) - prnewswire.com
SGGEF | $14.59 -47.52% 330
|
Technology Services
|
| O: -3.44%
H: 0.0%
C: 0.0%
SGPYY | $58.34 3.25% 8.7K
|
Professional, Scientific, and T...
|
| O: 0.19%
H: 0.21%
C: -1.0%
PCOR | $71.72 -0.04% 0.0% 980K
|
Information
|
| O: -1.33%
H: 0.79%
C: -3.48%
TRMB S | $57.84 -1.11% -1.12% 910K
|
Electronic Technology
|
| O: -0.71%
H: 0.59%
C: -0.18%
management construction software market
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.